Darshan Singh

Darshan Singh

Author is a pharmaceutical quality and regulatory professional with more than 23 years in drug manufacturing. He holds an M.Sc. in Organic Chemistry and a Diploma in Pharmacy. He has served as Quality Control Head, Quality Assurance Head and Plant Head, overseeing all manufacturing operations. He is co-founder and regulatory consultant at Laafon Galaxy Pharmaceuticals. He writes on SOPs, manufacturing processes, Schedule M compliance and drug pharmacology, and checks each claim against pharmacopoeial and regulatory sources.
  • Joined: July 17, 2024
  • Articles: 226

MHRA Compliance for Indian Exporters to the UK (2026)

MHRA Guidelines for Quality Manufacturers

Direct answer MHRA guidelines for the pharmaceutical industry are the UK’s Good Manufacturing Practice and Good Distribution Practice rules, consolidated by the Medicines and Healthcare products Regulatory Agency in Rules and Guidance for Pharmaceutical Manufacturers and Distributors — the “Orange…

Datroway (Datopotamab Deruxtecan): MOA, Approvals & India

Datroway (Datopotamab Deruxtecan)

Reviewed and updated: 12 August 2026. Regulatory status, indications and Indian commercial-availability status change frequently. Verify against the primary sources in the References before making any clinical, procurement or regulatory decision. In brief Datopotamab deruxtecan is a TROP2-directed antibody-drug conjugate…